HighTower Advisors’s Treace Medical Concepts TMCI Stock Holding History

HighTower Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.5K	Buy	13,687 +232	+2%	+$638	﹤0.01%	3721
2026 Q1	$18K	Sell	13,455 -140	-1%	-$279	﹤0.01%	3765
2025 Q4	$33.3K	Buy	+13,595	New	+$59K	﹤0.01%	3592
2024 Q4	–	Sell	-10,003	Closed	-$58K	–	4047
2024 Q3	$58K	Buy	+10,003	New	+$64.3K	﹤0.01%	3394
2023 Q4	–	Sell	-13,535	Closed	-$174K	–	3852
2023 Q3	$174K	Buy	13,535 +4,943	+58%	+$90.5K	﹤0.01%	2956
2023 Q2	$220K	Buy	8,592 +492	+6%	+$12.7K	﹤0.01%	2798
2023 Q1	$204K	Sell	8,100 -1,900	-19%	-$44.6K	﹤0.01%	2743
2022 Q4	$230K	Hold	10,000	–	–	﹤0.01%	2668
2022 Q3	$221K	Hold	10,000	–	–	﹤0.01%	2540
2022 Q2	$143K	Hold	10,000	–	–	﹤0.01%	2707
2022 Q1	$189K	Hold	10,000	–	–	﹤0.01%	2858
2021 Q4	$186K	Hold	10,000	–	–	﹤0.01%	2800
2021 Q3	$269K	Hold	10,000	–	–	﹤0.01%	2491
2021 Q2	$313K	Buy	+10,000	New	+$318K	﹤0.01%	2349

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HighTower Advisors's TMCI Position: Q2 2026 in Review

HighTower Advisors increased its Treace Medical Concepts (TMCI) stake by 1.7% in Q2 2026, buying an estimated $638 and bringing the position to 13,687 shares worth $54.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3721.

HighTower Advisors first reported a position in TMCI in Q2 2021 and has held it in 14 quarters since. The position peaked at $313K in Q2 2021. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

HighTower Advisors held 13,687 shares of Treace Medical Concepts worth $54.5K as of Q2 2026.
HighTower Advisors bought 232 Treace Medical Concepts shares in Q2 2026, an estimated $638.
Treace Medical Concepts made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3721 holding.
HighTower Advisors first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 14 quarters since.
HighTower Advisors's Treace Medical Concepts position peaked at $313K in Q2 2021.
116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.